V-Bio Ventures
Venture capital
UncertainLast verified 10 Nov 2026
Belgian venture capital firm co-creating and investing in early- to mid-stage European life sciences companies focused on therapeutics, drug discovery, and drug development.
1 deal in the last 24 months, latest 15 Oct 2025. Derived from its deals in the news.
Key facts
- Stages
- Series C+
- Sectors
- Biotech & pharma
- Eligible countries
- Not stated
- Provider based in
- Belgium
- Timing
- Rolling applications
- Focus
- therapeutics; drug discovery; drug development
- How to apply
- Apply route unknown
Recent deals
| Company | Round | Sectors | Amount | Role | Announced |
|---|---|---|---|---|---|
| Step Pharma · France | Series C+ | Biotech & pharma, Healthtech | €38M | lead | 15 Oct 2025 |
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
We are a life science Venture Capital fund that co-creates startups and invests in early- to mid-stage companies with high growth potential.
https://www.v-bio.ventures/ - Sectors
We focus on therapeutics, including both drug discovery and drug development.
https://www.v-bio.ventures/
Status history
- 10 Nov 2026: Rolling → Uncertain (freshness: investor activity)
- 6 Nov 2026: Rolling (first extraction)
Is something out of date?
Suggest an editTakes 10 seconds
Something else wrong? Report an error.
Work at V-Bio Ventures? Claim this profile to confirm what you invest in.